Analysts Shake Up Targets and Why $INTU $ZS and $ASND Could Be Poised for a Breakout

 TechStockTracker
 
  TechStockTracker
 
Follow  Message
 
 
 
TechStockTracker decode the complex world of finance and investments, with a special emphasis on the dynamic intersection of technology and dividend growth stocks.
 

•  17 Jun 2025
 

•   ASND  
   
  -0.84%
•   INTU  
   
  -0.80%
•   ZS  
   
  -0.70%

ANF Abercrombie & Fitch, saw its price target trimmed to $141 by JPMorgan. While that’s still nearly double its current price of $76.27, the adjustment may signal that the recent rally has gotten a bit ahead of itself. The brand has staged a powerful comeback in the retail space, but analysts appear to be baking in some normalization after explosive gains. Still, with a target well above its current price, ANF could remain a compelling mid-term story, just one that might need to catch its breath.

ASND Ascendis Pharma is enjoying a much brighter spotlight. Bank of America hiked its price target to $216 while reaffirming a Buy rating. With shares sitting at $178.40, that’s a bullish stance reflecting confidence in its pipeline and upcoming data catalysts. This pharma name has been on traders’ radars for months, and today’s revised target strengthens the bullish case as momentum builds.

FITB Fifth Third Bancorp got a quiet but meaningful nod from Wells Fargo, which raised its price target to $52. Trading at $38.26, the target implies a solid upside that could play well in a more dovish interest rate environment. Regional banks have struggled to find footing in recent quarters, but upgrades like this could mark a shift in sentiment and attract value-seeking investors.

Mizuho is turning heads with a bold call on INTU, raising its target to $875 on an optimistic QuickBooks growth outlook. Currently trading at $767.28, the upside is notable and suggests strong confidence in Intuit’s positioning within the small business and tax software space. With AI-powered tools and financial automation gaining ground, INTU may be quietly transforming into a tech-growth powerhouse once again.

JPMorgan sees more room to run for ZS lifting Zscaler price target from $292 to $348. At $305.09 today, the cybersecurity firm continues to ride the tailwind of enterprise cloud adoption and digital security demand. The analyst bump is validation for bulls who see ZS as a key beneficiary of ongoing IT spend even in a cautious economic environment.

Bottom line $INTU and $ASND are leading the analyst-fueled momentum wave, with clear upside targets and fundamental tailwinds. Keep your eyes on $ZS for a tech breakout, while FITB and ANF may offer longer plays as sentiment continues to evolve.